BUSINESS● LOWSep 11 · Sep 11, 2026, 3:48 PM
Neuronetics a new buy at B Riley on interventional psychiatry platform
Seeking Alpha Tech · global
Neuronetics has received a 'new buy' rating from B Riley, based on its interventional psychiatry platform. This suggests a positive outlook for the company's stock by financial analysts.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESS40m agoNotable analyst calls: Salesforce, Walmart and Lockheed Martin gain analyst support as tech downgrades mountSeeking Alpha TechBUSINESS50m agoInsurance stocks, TransUnion among winners; Banks, IREN in losers: week's financials wrapSeeking Alpha Tech